SeaSpine's first-quarter sales grew across its spinal implants and orthobiologics, and the company named new leadership.
Five things to know:
1. SeaSpine's total revenue was $50.7 million, and its U.S. sales were $45.5 million, according to financial results posted May 3. Both global and U.S. revenue were up 21 percent compared to the same time last year.
2. U.S. spinal implants and enabling technologies saw an increased revenue of 31 percent year over year at $24.2 million.
3. U.S. orthobiologics sales grew 12 percent year over year at $21.3 million.
4. Additional milestones for the company in the first quarter include implantation of the 50,000th NanoMetalene interbody device and the full commercial launch of multiple products.
5. The company on May 3 also announced two leadership appointments. John Bostjancic was named chief operating and financial officer and Hollis Winkler was named senior vice president of human resources.